These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 6804931)

  • 21. [High density lipoproteins: the status quo (author's transl)].
    Kostner GM
    Wien Klin Wochenschr; 1980 Oct; 92(19):665-72. PubMed ID: 7467341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Plasma levels of apoproteins B and A in relation to blood cholesterol and triglycerides. Distribution according to age and sex and influence of various risk factors (author's transl)].
    DeWailly P; Dedonder E; Fievet C; Campos E; Moulin S; Sezille G; Dubois G; Jaillard J
    Nouv Presse Med; 1981 Jan; 10(3):151-6. PubMed ID: 7220316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-density lipoproteins and the risk of atherosclerosis.
    Lees RS; Lees AM
    N Engl J Med; 1982 Jun; 306(25):1546-8. PubMed ID: 7078610
    [No Abstract]   [Full Text] [Related]  

  • 24. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma apolipoprotein B and VLDL-, LDL-, and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography.
    Whayne TF; Alaupovic P; Curry MD; Lee ET; Anderson PS; Schechter E
    Atherosclerosis; 1981 Jun; 39(3):411-24. PubMed ID: 6942843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atherosclerosis and apoproteins B and A-I.
    Kwiterovich PO; Sniderman AD
    Prev Med; 1983 Nov; 12(6):815-34. PubMed ID: 6427765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a new precipitation procedure for estimating high density lipoprotein cholesterol: precipitation of apolipoprotein B associated cholesterol with concanavalin A.
    Pascal M; Wülfert E
    Ann Biol Clin (Paris); 1981; 39(6):343-50. PubMed ID: 7325424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of procetofen on apolipoprotein A I and B concentrations in hyperlipoproteinemia.
    Viikari J; Solakivi-Jaakkola T; Lehtonen A
    Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):362-5. PubMed ID: 6811447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lipids, lipoproteins, apoproteins and clinical arteriopathic manifestations].
    Rouffy J; Chanu B; Bakir R; Goy-Loeper J; Miro I
    Pathol Biol (Paris); 1983 Apr; 31(4):261-70. PubMed ID: 6346239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The use of apolipoprotein B in clinical practice to determine the risk for atherosclerosis].
    Cabezas Castro M; Liem A
    Ned Tijdschr Geneeskd; 2003 Jul; 147(30):1445-8. PubMed ID: 12908345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Plasma lipoproteins and multiple myeloma. Variations of lipid constituents of HDL and apolipoproteins A1 and B].
    Hachem H; Favre G; Raynal G; Soula G
    Ann Biol Clin (Paris); 1983; 41(3):181-5. PubMed ID: 6414341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The APO A/APO B ratio in the screening of patients at cardiovascular risk].
    Artese D; Albani A; De Rosa G; Ricci E
    Minerva Med; 1983 Nov; 74(44):2677-82. PubMed ID: 6657118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The relationships of HDL- and LDL-cholesterol to cerebral infarction and to atherosclerosis--clinical and pathological study (author's transl)].
    Yamanouchi H; Tohgi H; Okabe H; Shimada H
    Nihon Ronen Igakkai Zasshi; 1981 May; 18(3):148-52. PubMed ID: 7289181
    [No Abstract]   [Full Text] [Related]  

  • 35. High-density lipoproteins, reverse cholesterol transport and atherosclerosis--recent developments.
    Berger GM
    S Afr Med J; 1984 Mar; 65(13):503-6. PubMed ID: 6710253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of high density lipoproteins in the regression of atherosclerosis.
    Badimon JJ; Fuster V; Badimon L
    Circulation; 1992 Dec; 86(6 Suppl):III86-94. PubMed ID: 1424054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The change in the levels of plasma high density lipoprotein (HDL) cholesterol and apoprotein A-I during acute myocardial infarction].
    Tsuji M; Ide H; Kawakami Y; Tateda K; Yokota H; Shibata J
    Nihon Ronen Igakkai Zasshi; 1983 Nov; 20(6):447-53. PubMed ID: 6425542
    [No Abstract]   [Full Text] [Related]  

  • 38. Lipid risk factors and atherosclerosis: what do we measure?
    Stein EA
    Scand J Clin Lab Invest Suppl; 1990; 198():3-8. PubMed ID: 2189208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory parameters as discriminators for peripheral atherosclerosis and stroke.
    Kostner GM; Marth E; Pfeiffer KH; Wege H
    Monogr Atheroscler; 1986; 14():119-23. PubMed ID: 3736549
    [No Abstract]   [Full Text] [Related]  

  • 40. [Quantitative determination of apolipoprotein A in human serum by laser nephelometry].
    Girault A; Loiseau D; Girault M
    Ric Clin Lab; 1981; 11 Suppl 2():19-29. PubMed ID: 6798675
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.